Humana Inc Etf Price To Earnings To Growth
HUM Etf | USD 304.18 6.07 2.04% |
Humana Inc fundamentals help investors to digest information that contributes to Humana's financial success or failures. It also enables traders to predict the movement of Humana Etf. The fundamental analysis module provides a way to measure Humana's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Humana etf.
Humana |
Humana Inc ETF Price To Earnings To Growth Analysis
Humana's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Humana Price To Earnings To Growth | 1.37 X |
Most of Humana's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Humana Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition |
Based on the latest financial disclosure, Humana Inc has a Price To Earnings To Growth of 1.3663 times. This is much higher than that of the Health Care Providers & Services family and significantly higher than that of the Health Care category. The price to earnings to growth for all United States etfs is notably lower than that of the firm.
Humana Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Humana's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of Humana could also be used in its relative valuation, which is a method of valuing Humana by comparing valuation metrics of similar companies.Humana is currently under evaluation in price to earnings to growth as compared to similar ETFs.
Humana ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Humana's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Humana's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Humana Fundamentals
Return On Equity | 0.0784 | ||||
Return On Asset | 0.0401 | ||||
Profit Margin | 0.01 % | ||||
Operating Margin | 0.03 % | ||||
Current Valuation | 43.8 B | ||||
Shares Outstanding | 120.41 M | ||||
Shares Owned By Insiders | 0.21 % | ||||
Shares Owned By Institutions | 94.77 % | ||||
Number Of Shares Shorted | 4.38 M | ||||
Price To Earning | 19.12 X | ||||
Price To Book | 2.04 X | ||||
Price To Sales | 0.31 X | ||||
Revenue | 106.37 B | ||||
Gross Profit | 17.18 B | ||||
EBITDA | 4.93 B | ||||
Net Income | 2.49 B | ||||
Cash And Equivalents | 5.06 B | ||||
Cash Per Share | 143.73 X | ||||
Total Debt | 11.66 B | ||||
Debt To Equity | 0.85 % | ||||
Current Ratio | 1.53 X | ||||
Book Value Per Share | 145.88 X | ||||
Cash Flow From Operations | 3.98 B | ||||
Short Ratio | 1.20 X | ||||
Earnings Per Share | 11.45 X | ||||
Price To Earnings To Growth | 1.37 X | ||||
Target Price | 288.15 | ||||
Number Of Employees | 67.6 K | ||||
Beta | 0.52 | ||||
Market Capitalization | 35.9 B | ||||
Total Asset | 47.06 B | ||||
Retained Earnings | 27.54 B | ||||
Working Capital | 366.27 M | ||||
Current Asset | 2.76 B | ||||
Current Liabilities | 2.39 B | ||||
Annual Yield | 0.01 % | ||||
Five Year Return | 0.64 % | ||||
Net Asset | 47.06 B | ||||
Last Dividend Paid | 3.54 |
About Humana Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Humana Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Humana using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Humana Inc based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Humana Etf
Humana financial ratios help investors to determine whether Humana Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humana with respect to the benefits of owning Humana security.